Urologist and radiologist contributions to variation in prostate cancer detection at fusion biopsy
BJU International · 2026-07 · 138 (1) · 156-163
DOI: 10.1111/bju.70308 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJU International, online erschienen am 07.05.2026. Verfasst von Daniel Triner und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Stanford University, Stanford, CA, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Image-Guided Biopsy, Radiologists, Urologists. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Blue Cross Blue Shield of Michigan Foundation.
Abstract (Originalsprache)
Objectives
To quantify the relative contribution of radiologists and urologists to variability in clinically significant prostate cancer (CSPC) detection across multiparametric magnetic resonance imaging (mpMRI)‐guided prostate fusion biopsies and to determine whether this differed across Prostate Imaging‐Reporting And Data System (PI‐RADS) categories. Subjects, Patients and Methods We analysed biopsy‐naïve men within the Michigan Urological Surgery Improvement Collaborative (MUSIC) who underwent fusion biopsy between August 2017 and November 2021. The primary outcome was the proportion of variance in CSPC detection (Gleason score ≥3 + 4) at targeted regions of interest that was explained by individual urologists and radiologists. We used generalised linear mixed‐effects models to partition variance and estimate intraclass correlation coefficients (ICCs) for radiologist‐ and urologist‐level effects for PI‐RADS score 3–5 lesions. We calculated the median odds ratio (MOR) to quantify the expected difference in odds of CSPC detection when comparing a randomly selected higher‐ vs lower‐detecting provider from the same distribution.
Results
Among 1544 men with 2045 targeted lesions, mpMRIs were interpreted by 115 radiologists and biopsies performed by 86 urologists. For PI‐RADS score 3 lesions, urologists (ICC = 0.15, MOR = 2.07) accounted for greater variance in CSPC detection than radiologists (ICC = 0.07, MOR = 1.61). For PI‐RADS score 4, both urologist (ICC = 0.05, MOR = 1.49) and radiologist (ICC = 0.07, MOR = 1.61) contributed modestly. For PI‐RADS score 5, radiologists (ICC = 0.17, MOR = 2.19) explained a larger proportion of variance than urologists (ICC = 0.01, MOR = 1.19), suggesting individual radiologists meaningfully impact CSPC detection of high‐risk lesions.
Conclusions
For PI‐RADS score 3 lesions, the specific urologist performing the biopsy was a strong source of variation, while for PI‐RADS score 5 lesions, the radiologist had greater influence on CSPC detection rates. Optimising MRI acquisition and interpretation, ensuring accurate fusion registration, and improving biopsy accuracy are critical to improving diagnostic consistency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Stanford University, Stanford, CA, USA.
- Department of Urology, Wayne State University School of Medicine, Detroit, MI, USA.
- Department of Urology, Michigan Medicine, Ann Arbor, MI, USA.
- Comprehensive Urology, Royal Oak, MI, USA.
- Department of Radiology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
- Department of Urology, Henry Ford Health System, Detroit, MI, USA.
ORCID-Profile: Daniel Triner, Kevin B Ginsburg
Förderung
- Blue Cross Blue Shield of Michigan Foundation
Zitieren
APA
Triner, D., Ginsburg, K. B., Moser, A., Labardee, C., Korman, H., Domina, J., Cher, M. L., Peabody, J., Semerjian, A., Purysko, A., George, A. K., Borza, T., Krumm, A. E., & Michigan Urological Surgery Improvement Collaborative (MUSIC) (2026). Urologist and radiologist contributions to variation in prostate cancer detection at fusion biopsy. BJU International, 138(1), 156-163. https://doi.org/10.1111/bju.70308
Vancouver
Triner D, Ginsburg KB, Moser A, Labardee C, Korman H, Domina J, et al. Urologist and radiologist contributions to variation in prostate cancer detection at fusion biopsy. BJU International. 2026;138(1):156-163. doi:10.1111/bju.70308
BibTeX
@article{Triner2026,
author = {Triner, Daniel and Ginsburg, Kevin B and Moser, Ana and Labardee, Corinne and Korman, Howard and Domina, Jason and Cher, Michael L and Peabody, James and Semerjian, Alice and Purysko, Andrei and George, Arvin K and Borza, Tudor and Krumm, Andrew E and Michigan Urological Surgery Improvement Collaborative (MUSIC), Michigan Urological Surgery Improvement Collaborative (MUSIC)},
title = {Urologist and radiologist contributions to variation in prostate cancer detection at fusion biopsy},
journal = {BJU International},
year = {2026},
volume = {138},
number = {1},
pages = {156--163},
doi = {10.1111/bju.70308}
}
EUVIMED